Jounce Therapeutics News

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Jounce Therapeutics Inc JNCE NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.71 9.14% 8.48 19:20:03
Open Price Low Price High Price Close Price Prev Close
7.86 7.80 8.62 8.48 7.77
more quote information »

Recent News

Date Time Source Heading
9/17/202116:16EDGARStatement of Changes in Beneficial Ownership (4)
9/17/202113:39EDGARStatement of Changes in Beneficial Ownership (4)
9/15/202108:19EDGARStatement of Changes in Beneficial Ownership (4)
9/15/202108:16EDGARInitial Statement of Beneficial Ownership (3)
9/15/202108:13EDGARCurrent Report Filing (8-k)
9/15/202108:00GLOBEJounce Therapeutics Appoints Jigar Raythatha to its Board of..
9/02/202108:00GLOBEJounce Therapeutics to Present at Upcoming Investor..
9/01/202116:21EDGARStatement of Ownership (sc 13g)
8/05/202112:34EDGARQuarterly Report (10-q)
8/05/202107:10SEEKJounce Therapeutics EPS beats by $0.28, beats on revenue
8/05/202107:00GLOBEJounce Therapeutics Reports Second Quarter 2021 Financial..
8/05/202106:37EDGARCurrent Report Filing (8-k)
7/29/202108:00GLOBEJounce Therapeutics to Announce Second Quarter 2021..
7/07/202108:00GLOBEJounce Therapeutics to Participate in William Blair’s..
6/23/202116:43EDGARCurrent Report Filing (8-k)
6/23/202108:00GLOBEJounce Therapeutics Provides Update on INNATE Study and..
6/22/202116:50EDGARStatement of Changes in Beneficial Ownership (4)
6/22/202116:50EDGARStatement of Changes in Beneficial Ownership (4)
6/22/202116:48EDGARStatement of Changes in Beneficial Ownership (4)
6/22/202116:47EDGARStatement of Changes in Beneficial Ownership (4)
6/22/202116:46EDGARStatement of Changes in Beneficial Ownership (4)
6/16/202108:00GLOBEJounce Therapeutics to Host Virtual R&D Day on June 23, 2021
6/15/202113:25DJNJounce Therapeutics Shares Rise 13% on IND Clearance for..
6/15/202109:51DJNJounce Therapeutics Gets FDA Clearance for Cancer Treatment..
6/15/202108:00GLOBEJounce Therapeutics Achieves First Milestone in Exclusive..
6/14/202116:20EDGARStatement of Changes in Beneficial Ownership (4)
6/14/202108:00GLOBEJounce Therapeutics to Participate in Fireside Chat at the..
6/04/202109:00GLOBEJounce Therapeutics Presents Trial in Progress Posters on..
5/27/202117:43EDGARStatement of Changes in Beneficial Ownership (4)
5/20/202106:08EDGARNotice of Effectiveness (effect)
5/04/202116:27EDGARSecurities Registration Statement (simplified Form) (s-3)
5/04/202107:10EDGARCurrent Report Filing (8-k)
5/04/202106:38SEEKJounce Therapeutics EPS beats by $0.01, misses on revenue
5/04/202106:30GLOBEJounce Therapeutics Reports First Quarter 2021 Financial..
4/28/202108:00GLOBEJounce Therapeutics to Present Trial in Progress Posters on..
4/27/202108:00GLOBEJounce Therapeutics to Announce First Quarter 2021 Financial..
4/26/202116:43EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
4/26/202116:42EDGARProxy Statement (definitive) (def 14a)
4/12/202108:00GLOBEJounce Therapeutics Appoints Dmitri Wiederschain, Ph.D., as..
4/10/202108:31GLOBEJounce Therapeutics Presents Preclinical Data from..
3/15/202116:17EDGARStatement of Changes in Beneficial Ownership (4)
3/15/202116:16EDGARStatement of Changes in Beneficial Ownership (4)
3/12/202111:10GLOBEJounce Therapeutics Announces Closing of Public Offering and..
3/10/202116:49EDGARCurrent Report Filing (8-k)
3/10/202116:30GLOBEJounce Therapeutics to Present Preclinical Data from..
3/10/202101:34SEEKJounce Therapeutics raises $56M via equity offering
3/09/202122:17GLOBEJounce Therapeutics Announces Pricing of $56.25 Million..
3/09/202117:04EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
3/09/202116:08SEEKJounce Therapeutics launches stock offering
3/09/202116:01GLOBEJounce Therapeutics Announces Proposed Offering of Common..
See more news about this stock »
Your Recent History
Jounce The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210923 02:39:22